|Articles|August 23, 2022
Worldwide Clinical Trials Expands With New Lab at Bioanalytical Center of Excellence
CRO expands its Early Phase large molecule capabilities and services with a new 15,000 square foot dedicated lab.
Advertisement
Worldwide Clinical Trials, Inc. has expanded its Early Phase large molecule capabilities and services with a new 15,000 square foot dedicated lab at its Bioanalytical Center of Excellence in Austin, TX.
The added capacity enables Worldwide to provide its sponsors with optimized sample processing and analysis workflows for minimal turnaround times.
Read more about the new facility
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
2
Applying AI to Automate Workflows Without Disrupting Sites
3
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
4
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
5